The Supreme Court has temporarily blocked a ruling from a federal judge in Texas that would have put a pause on the Food and Drug Administration's approval of mifepristone, a medicine used in two-step medication abortions. This decision will allow for nationwide access to mifepristone to be preserved until Wednesday, when the justices will consider next steps. Abortion clinics are readying contingency plans in case mifepristone's FDA approval is overturned.
